-
synthesis of novel structures chosen from understanding of initial series of compounds and their performance from MRC grant MR/T015845/1) in terms of measurements of efficacy using a validated in vivo model
-
to identify the historical, structural, and contextual drivers of disease risk and inequity, and map pathways and interactions among determinants to inform disease mapping and modelling. The RA will lead the
Enter an email to receive alerts for structures-"https:" "https:" "https:" positions